JPMorgan lowered the firm’s price target on 3M to $110 from $118 and keeps a Neutral rating on the shares. The new target reflects reflect the remaining company post the healthcare spin, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMM: